PPK (ASX:PPK) share price wobbles on joint venture news

The company will manufacture anti-viral and anti-bacterial face masks with a new partner…

| More on:
A group of young people clowning around wearing COVID-19 masks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in PPK Group Limited (ASX: PPK) are up and down in morning trade today. This comes after the boron nitride nanotubes (BNNT) company announced a joint venture to manufacture anti-viral and anti-bacterial face masks.

At the time of writing, the PPK share price is down 0.6% trading at $19.92, after touching a high of $20.6 near the open.

PPK eyes new revenue stream

In today's statement, PPK advised it has teamed up with Xefco to form a new company called Survivon.

Founded in 2018, Xefco uses advanced manufacturing methods to create textile technologies with additional functional benefits. In particular, the group focuses on antiviral technology.

The newly-formed business will immediately start local production of anti-viral and antibacterial face masks using Xefco's ground-breaking technology. PPK advised it has purchased a mask factory in Brisbane and has orders already in hand. Up to 5 million masks can be produced each month.

The company said the medical-grade face masks would contain an ultra-thin coating of 99.95% pure copper developed by Xefco and Deakin University.

An independent study by the Peter Doherty Institute for Infection and Immunity revealed positive results in May. It showed that the new treated textiles were able to inactivate the virus associated with COVID-19 by 97.79% in 5 minutes, and 99.95% in 15 minutes.

PPK and Xefco will each own 47.6% of Survivon with the remaining balance held by senior manager, Matthew Bailey.

Under the terms of the partnership, PPK will contribute $4.5 million in cash on completion in exchange for its equity, less the transfer of PPK's recently acquired business, Mask Innovation to Survivon for approximately $1.6 million.

The cash will be used as ordinary working capital for the new business.

Management commentary

PPK executive chair Robin Levison commented:

The chance to combine the manufacturing assets of PPK's Mask Innovation business with leading science developed by Xefco in conjunction with Deakin University represents a tremendous commercialisation opportunity with global application.

It is also an incredibly timely one and yields a likelihood of making a very practical and immediate difference in combating one of the great healthcare issues of our time.

About the PPK share price

Over the last 12 months, the PPK share price has accelerated, gaining around 420% since this time last year. Year-to-date, its shares have advanced 240%.

PPK presides a market capitalisation of roughly $1.78 billion, and has 89.29 million shares on its books.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to the trading week for investors this Friday.

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

3 ASX All Ords shares smashing the benchmark this week

Investors are sending these three ASX All Ords shares rocketing 18% to more than 29% this week. But why?

Read more »

watch
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why APA, Flight Centre, Reece, and Transurban shares are falling today

These shares are having a tough finish to the week. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Alliance Aviation, BHP, Boss Energy, and Orthocell shares are racing higher

These shares are ending the week on a positive note. But why?

Read more »

Mum playing with her baby boy holding him on her tummy as she lays down while smiling about the Bubs share price going up today
Broker Notes

Following two unfortunate incidents, what's Macquarie's price target on Monash IVF shares?

Is Monash IVF a buying opportunity?

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Macquarie tips 18% return for this ASX 200 stock

The broker thinks this blue chip's profits are going to rebound in FY 2026.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in FY26

These shares are among the best to buy in the new financial year according to its analysts.

Read more »